Adrenal insufficiency during septic shock

Critical Care Medicine

Volumn 31, Issue 1, 2003, Pages 141-145

  Marik, Paul E ^a   Zaloga, Gary P ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal insufficiency; Corticotropin; Cortisol; Endocrine; Glucocorticoids; Hypothalamic pituitary adrenal axis; Sepsis; Shock

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; DOSE RESPONSE; FEMALE; HEMODYNAMICS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEPTIC SHOCK; STANDARD;

ADRENAL CORTEX FUNCTION TESTS; ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SHOCK, SEPTIC;

EID: 0037250881     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200301000-00022     Document Type: Article

References (60)

1. Saito T, Takanashi M, Gallagher E, et al: Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: Hemodynamic study and beta-adrenergic receptor assay. Intensive Care Med 1995; 21:204-210
2. Barnes PJ: Beta-adrenergic receptors and their regulation. Am J Respir Crit Care Med 1995; 152:838-860
3. Ullian ME: The role of corticosteroids in the regulation of vascular tone. Cardiovasc Res 1999; 41:55-64
4. Briegel J, Scheelling G, Haller M, et al: A comparison of the adrenocortical response during septic shock and after complete recovery. Intensive Care Med 1996; 22:894-899
5. Beishuizen A, Vermes I, Hylkema BS, et al: Relative eosinophilia and functional adrenal insufficiency in critically ill patients. Lancet 1999; 353:1675-1676
6. Drucker D, McLaughlin J: Adrenocortical dysfunction in acute medical illness. Crit Care Med 1986; 14:789-791
7. Drucker D, Shandling M: Variable adrenocortical function in acute medical illness. Crit Care Med 1985; 13:477-479
8. Zaloga GP, Marik P: Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17:25-42
9. Streeten DHP: What test for hypothalamic-pituitary adrenocortical insufficiency? Lancet 1999; 354:179-180
10. Chernow B, Rainey TR, Lake CR: Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982; 10:409-416
11. Hart BB, Stanford GG, Ziegler MG, et al: Catecholamines: Study of interspecies variation. Crit Care Med 1989; 17:1203-1218
12. Lamberts SW, Bruining HA, de Jong FH: Corticosteroid therapy in severe illness. N Engl J Med 1997; 337:1285-1292
13. Melby JC, Spink WW: Comparative studies of adrenal cortisol function and cortisol metabolism in healthy adults and in patients with septic shock due to infection. J Clin Invest 1958; 37:1791-1798
14. Parker LN, Levin ER, Lifrak ET: Evidence for adrenocortical adaptation to severe illness. J Clin Endocrinol Metab 1985; 60:947-952
15. Richards ML, Caplan RH, Wickus GG, et al: The rapid low-dose (1 microgram) cosyntropin test in the immediate postoperative period: Results in elderly subjects after major abdominal surgery. Surgery 1999; 125:431-440
16. Schein RMH, Sprung CL, Marcial E: Plasma cortisol levels in patients with septic shock. Crit Care Med 1990; 18:259-263
17. Soni A, Pepper GM, Wyrwinski PM, et al: Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98:266-271
18. Bouachour G, Tirot P, Gouello JP, et al: Adrenocortisol function during septic shock. Intensive Care Med 1995; 21:57-62
19. Reincke M, Allolio B, Wurth G, et al: The hypothalamic-pituitary-adrenal axis in critical illness: Response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 1993; 77:151-156
20. Sibbald WJ, Short A, Cohen MP, et al: Variations in adrenocortical responsiveness during severe bacterial infections. Unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977; 186:29-33
21. Marik PE, Rotella LC, Zaloga GP: Secondary adrenal insufficiency is common in critically ill patients. Abstr. Crit Care Med 2001; 29(Suppl):A163
22. Broide J, Soferman R, Kivity S, et al: Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 1995; 80:1243-1246
23. Mayenknecht J, Diederich S, Bahr V, et al: Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998; 83:1558-1562
24. Rasmuson S, Olsson T, Hagg E: A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996; 44:151-156
25. Tordjman K, Jaffe A, Grazas N, et al: The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80:1301-1305
26. Abdu TA, Elhadd TA, Neary R, et al: Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999; 84:838-843
27. Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
28. Grinspoon SK, Bilezikian JP: HIV disease and the endocrine system. N Engl J Med 1992; 327:1360-1365
29. Hofbauer LC, Heufelder AE: Endocrine implications of human immunodeficiency virus infection. Medicine 1996; 75:262-278
30. Membreno L, Irony I, Dere W, et al: Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1987; 65:482-487
31. Oelkers W: Adrenal insufficiency. N Engl J Med 1996; 335:1206-1212
32. Marik PE, Varon J: Sepsis: State of the art. Dis Mon 2001; 47:463-532
33. Rivers EP, Gaspari M, Abi Saad G, et al: Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001; 119:889-896
34. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
35. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
36. Oppert M, Reinicke A, Graf KJ, et al: Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med 2000; 26:1747-1755
37. Annane D: Effects of the combination of hydrocortisone-Fludro-cortisone on mortality in septic shock. Crit Care Med 2000; 28(Suppl):A46
38. Sakaue M, Hoffman BB: Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J Clin Invest 1991; 88:385-389
39. Collins S, Caron MG, Lefkowitz RJ: Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 1988; 263:9067-9070
40. MacMicking JD, Nathan C, Hom G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995; 81:641-650
41. Landry DW, Oliver JA: Pathogenesis of vasodilatory shock. N Engl J Med 2001; 345:588-595
42. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-1125
43. Tsuneyoshi I, Yamada H, Kakihana Y, et al: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001; 29:487-493
44. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
45. Marik P, Zaloga G: Prognostic value of cortisol in septic shock. JAMA 2000; 284:308-309
46. Marik PE, Zaloga GP: Adrenal insufficiency in the critically ill: A new look at an old problem. Chest, In Press
47. Catalano RD, Parameswaran V, Ramachandran J, et al: Mechanisms of adrenocortical depression during Escherichia coli shock. Arch Surg 1984; 119:145-150
48. Keri G, Parameswaran V, Trunkey DD, et al: Effects of septic shock plasma on adrenocortical cell function. Life Sci 1981; 28:1917-1923
49. Melby JC, Egdahl RH, Spink WW: Secretion and metabolism of cortisol after injection of endotoxin. J Lab Clin Med 1960; 56:50-62
50. Bateman A, Singh A, Kral T, et al: The immune-hypothalamic-pituitary-adrenal axis. Endocr Rev 1989; 10:92-112
51. Gaillard RC, Turnill D, Sappino P, et al: Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors. Endocrinology 1990; 127:101-106
52. Jaattela M, Ilvesmaki V, Voutilainen R, et al: Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991; 128:623-629
53. Zhu Q, Solomon S: Isolation and mode of action of rabbit corticostatic (antiadrenocorticotropin) peptides. Endocrinology 1992; 130:1413-1423
54. Masera RG, Bateman A, Muscettola M, et al: Corticostatins/defensins inhibit in vitro NK activity and cytokine production by human peripheral blood mononuclear cells. Regul Pept 1996; 62:13-21
55. Tominaga T, Fukata J, Hayashi Y, et al: Distribution and characterization of immunoreactive corticostatin in the hypothalamic-pituitary-adrenal axis. Endocrinology 1992; 130:1593-1598
56. McCallum RE, Stith RD: Endotoxin-induced inhibition of steroid binding by mouse liver cytosol. Circ Shock 1982; 9:357-367
57. Pariante CM, Pearce BD, Pisell TL, et al: The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology 1999; 140:4359-4366
58. Schuler JJ, Erve PR, Schumer W: Glucocorticoid effect on hepatic carbohydrates metabolism in the endotoxin-shocked monkey. Ann Surg 1976; 183:345-354
59. The Veterans Administration Systemic Sepsis Cooperative Study Group: Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317:659-665
60. Bone RC, Fisher CJ, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658